TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2022

Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years.

Brandon Essink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.